Jeonjinbio Co. Ltd (110020) - Total Liabilities

Latest as of September 2025: ₩1.27 Billion KRW ≈ $862.54K USD

Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has total liabilities worth ₩1.27 Billion KRW (≈ $862.54K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Jeonjinbio Co. Ltd (110020) cash flow conversion to assess how effectively this company generates cash.

Jeonjinbio Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Jeonjinbio Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Jeonjinbio Co. Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Jeonjinbio Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Jeonjinbio Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Perfect Moment Ltd. NASDAQ:PMNT	USA	$13.98 Million
Pelikan International Corp KLSE:5231	Malaysia	RM76.02 Million
Copaur Minerals Inc V:CPAU	Canada	CA$182.98K
Smartlink Holdings Limited NSE:SMARTLINK	India	Rs639.48 Million
Anugerah Kagum Karya Utama Tbk PT JK:AKKU	Indonesia	Rp283.51 Billion
Toppoint Holdings Inc. NYSE MKT:TOPP	USA	$1.55 Million
3R Games SA WAR:3RG	Poland	zł539.00K
Sambhaav Media Limited NSE:SAMBHAAV	India	Rs130.26 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Jeonjinbio Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Jeonjinbio Co. Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jeonjinbio Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jeonjinbio Co. Ltd (2015–2024)

The table below shows the annual total liabilities of Jeonjinbio Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩1.19 Billion ≈ $807.71K	-89.62%
2023-12-31	₩11.48 Billion ≈ $7.78 Million	+37.39%
2022-12-31	₩8.36 Billion ≈ $5.66 Million	-40.38%
2021-12-31	₩14.02 Billion ≈ $9.50 Million	+89.15%
2020-12-31	₩7.41 Billion ≈ $5.02 Million	+111.04%
2019-12-31	₩3.51 Billion ≈ $2.38 Million	+9.45%
2018-12-31	₩3.21 Billion ≈ $2.17 Million	-16.15%
2017-12-31	₩3.83 Billion ≈ $2.59 Million	+7.86%
2016-12-31	₩3.55 Billion ≈ $2.40 Million	-55.35%
2015-12-31	₩7.95 Billion ≈ $5.39 Million	--

About Jeonjinbio Co. Ltd

KQ:110020 Korea Specialty Chemicals

Market Cap

$14.37 Million

₩21.20 Billion KRW

Market Cap Rank

#25946 Global

#1939 in Korea

Share Price

₩2340.00

Change (1 day)

-1.68%

52-Week Range

₩1792.00 - ₩4445.00

All Time High

₩16700.00